224 related articles for article (PubMed ID: 27815019)
1. Expression of netrin-1 by hypoxia contributes to the invasion and migration of prostate carcinoma cells by regulating YAP activity.
Chen H; Chen Q; Luo Q
Exp Cell Res; 2016 Dec; 349(2):302-309. PubMed ID: 27815019
[TBL] [Abstract][Full Text] [Related]
2. The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.
Zhang L; Yang S; Chen X; Stauffer S; Yu F; Lele SM; Fu K; Datta K; Palermo N; Chen Y; Dong J
Mol Cell Biol; 2015 Apr; 35(8):1350-62. PubMed ID: 25645929
[TBL] [Abstract][Full Text] [Related]
3. Netrin-1 promotes metastasis of gastric cancer by regulating YAP activity.
Yin K; Dang S; Cui L; Fan X; Wang L; Xie R; Qu J; Shang M; Chen J; Xu Z
Biochem Biophys Res Commun; 2018 Jan; 496(1):76-82. PubMed ID: 29305865
[TBL] [Abstract][Full Text] [Related]
4. Netrin-1 induces epithelial-mesenchymal transition and promotes hepatocellular carcinoma invasiveness.
Yan W; Han P; Zhou Z; Tu W; Liao J; Li P; Liu M; Tian D; Fu Y
Dig Dis Sci; 2014 Jun; 59(6):1213-21. PubMed ID: 24442237
[TBL] [Abstract][Full Text] [Related]
5. Netrin-1 exerts oncogenic activities through enhancing Yes-associated protein stability.
Qi Q; Li DY; Luo HR; Guan KL; Ye K
Proc Natl Acad Sci U S A; 2015 Jun; 112(23):7255-60. PubMed ID: 26039999
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness.
Bizzarro V; Belvedere R; Migliaro V; Romano E; Parente L; Petrella A
Cell Adh Migr; 2017 May; 11(3):247-260. PubMed ID: 27834582
[TBL] [Abstract][Full Text] [Related]
7. CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling.
Lai CJ; Lin CY; Liao WY; Hour TC; Wang HD; Chuu CP
Cells; 2019 Mar; 8(4):. PubMed ID: 30935014
[TBL] [Abstract][Full Text] [Related]
8. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis.
Rodrigues S; De Wever O; Bruyneel E; Rooney RJ; Gespach C
Oncogene; 2007 Aug; 26(38):5615-25. PubMed ID: 17334389
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
[TBL] [Abstract][Full Text] [Related]
10. Chronic hypoxia-induced slug promotes invasive behavior of prostate cancer cells by activating expression of ephrin-B1.
Iwasaki K; Ninomiya R; Shin T; Nomura T; Kajiwara T; Hijiya N; Moriyama M; Mimata H; Hamada F
Cancer Sci; 2018 Oct; 109(10):3159-3170. PubMed ID: 30058095
[TBL] [Abstract][Full Text] [Related]
11. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.
Liu CY; Yu T; Huang Y; Cui L; Hong W
J Biol Chem; 2017 Jun; 292(22):9420-9430. PubMed ID: 28408625
[TBL] [Abstract][Full Text] [Related]
12. PTPN14 acts as a candidate tumor suppressor in prostate cancer and inhibits cell proliferation and invasion through modulating LATS1/YAP signaling.
Wang R; Du Y; Shang J; Dang X; Niu G
Mol Cell Probes; 2020 Oct; 53():101642. PubMed ID: 32645410
[TBL] [Abstract][Full Text] [Related]
13. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
[TBL] [Abstract][Full Text] [Related]
14. YAP knockdown inhibits proliferation and induces apoptosis of human prostate cancer DU145 cells.
Jin X; Zhao W; Zhou P; Niu T
Mol Med Rep; 2018 Mar; 17(3):3783-3788. PubMed ID: 29286134
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of HuR represses osteosarcoma cells migration, invasion and stemness through inhibition of YAP activation and increases susceptibility to chemotherapeutic agents.
Xu W; Chen C; Xu R; Li Y; Hu R; Li Z; Zhu X
Biomed Pharmacother; 2018 Jun; 102():587-593. PubMed ID: 29597092
[TBL] [Abstract][Full Text] [Related]
16. Hippo signaling promotes JNK-dependent cell migration.
Ma X; Wang H; Ji J; Xu W; Sun Y; Li W; Zhang X; Chen J; Xue L
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):1934-1939. PubMed ID: 28174264
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
18. Yes-associated protein (YAP) expression is involved in epithelial-mesenchymal transition in hepatocellular carcinoma.
Wang S; Li H; Wang G; Zhang T; Fu B; Ma M; Quan Z; Chen G
Clin Transl Oncol; 2016 Feb; 18(2):172-7. PubMed ID: 26254048
[TBL] [Abstract][Full Text] [Related]
19. Interactional expression of netrin-1 and its dependence receptor UNC5B in prostate carcinoma.
Kong CZ; Liu J; Liu L; Zhang Z; Guo KF
Tumour Biol; 2013 Oct; 34(5):2765-72. PubMed ID: 23666553
[TBL] [Abstract][Full Text] [Related]
20. PEBP4 silencing inhibits hypoxia-induced epithelial-to-mesenchymal transition in prostate cancer cells.
Li W; Dong Y; Zhang B; Kang Y; Yang X; Wang H
Biomed Pharmacother; 2016 Jul; 81():1-6. PubMed ID: 27261570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]